The malignant phenotype-associated microRNA in gastroenteric, hepatobiliary and pancreatic carcinomas

Bibliography

• Shapira I, Sultan K, Mehrotra B, Budman DR. Emerging role of small ribonucleic acids in gastrointestinal tumors. Crit Rev Oncol Hematol 2010: published online 6 Feb 2010, doi:10.1016/j.critrevonc.2010.01.013
   Google Scholar
• Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11(9):597-610
   PubMed Web of Science ®Google Scholar
• Fabbri M, Calin GA. Epigenetics and miRNAs in human cancer. Adv Genet 2010;70:87-99
   Google Scholar
• Skotheim RI, Nees M. Alternative splicing in cancer: noise, functional, or systematic? Int J Biochem Cell Biol 2007;39:1432-49
   PubMed Web of Science ®Google Scholar
• Feber A, Xi L, Luketich JD, MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 2008;135:255-60
   PubMed Web of Science ®Google Scholar
• Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2009: published online 22 Dec 2009, doi: 10.1016/j.biocel.2009.12.014
   Google Scholar
• Hong L, Han Y, Zhang H, The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma Ann Surg 2010;251(6):1056-63
   PubMed Web of Science ®Google Scholar
• Guo Y, Chen Z, Zhang L, Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008;68:26-33
   PubMed Web of Science ®Google Scholar
• Hong L, Han Y, Zhang H, The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann Surg 2010;251:1056-63
   PubMed Web of Science ®Google Scholar
• Cho WC. MicroRNAs in cancer-from research to therapy. Biochim Biophys Acta 2010;1805:209-17
   PubMed Web of Science ®Google Scholar
• Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010;16:531-7
   PubMed Web of Science ®Google Scholar
• Hong L, Li S, Liu L, The value of MG7-Ag and COX-2 for predicting malignancy in gastric precancerous lesions. Cell Biol Int 2010;34(9):873-6
   PubMed Web of Science ®Google Scholar
• Ueda T, Volinia S, Okumura H, Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46
   PubMed Web of Science ®Google Scholar
• Ando T, Yoshida T, Enomoto S, DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 2009;124:2367-74
   PubMed Web of Science ®Google Scholar
• Lai KW, Koh KX, Loh M, MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur J Cancer 2010;46:1456-63
   PubMed Web of Science ®Google Scholar
• Su H, Yang JR, Xu T, MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 2009;69(3):1135-42
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhu W, Zhang J, MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun 2010;395:275-80
   PubMed Web of Science ®Google Scholar
• Liu T, Tang H, Lang Y, MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009;273(2):233-42
   PubMed Web of Science ®Google Scholar
• Guo X, Guo L, Ji J, miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem Biophys Res Commun 2010;398(1):1-6
   PubMed Web of Science ®Google Scholar
• Chu D, Adler DG. Malignant biliary tract obstruction: evaluation and therapy. J Natl Compr Canc Netw 2010;8(9):1033-44
   PubMed Web of Science ®Google Scholar
• Chen L, Yan HX, Yang W, The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. J Hepatol 2009;50:358-69
   PubMed Web of Science ®Google Scholar
• Meng F, Henson R, Lang M, Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 2006;130:2113-29
   PubMed Web of Science ®Google Scholar
• Chen Y, Xie D, Yin Li W, RNAi targeting EZH2 inhibits tumor growth and liver metastasis of pancreatic cancer in vivo. Cancer Lett 2010;297(1):109-16
   PubMed Web of Science ®Google Scholar
• Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett 2010;292:8-16
   PubMed Web of Science ®Google Scholar
• Dillhoff M, Wojcik SE, Bloomston M. MicroRNAs in solid tumors. J Surg Res 2009;154:349-54
   PubMed Web of Science ®Google Scholar
• Xia L, Zhang D, Du R, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int J Cancer 2008;123:372-9
   PubMed Web of Science ®Google Scholar
• Bloomston M, Frankel WL, Petrocca F, MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297:1901-8
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Funel N, Peters GJ, MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010;70:4528-38
   PubMed Web of Science ®Google Scholar
• Torrisani J, Bournet B, du Rieu MC, let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression. Hum Gene Ther 2009;20:831-44
   PubMed Web of Science ®Google Scholar
• Weiss FU, Marques IJ, Woltering JM, Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology 2009;137:2136-45
   PubMed Web of Science ®Google Scholar
• Liu C, Yu J, Yu S, MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010;53:98-107
   PubMed Web of Science ®Google Scholar
• Gramantieri L, Fornari F, Callegari E, MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008;12:2189-204
   PubMed Web of Science ®Google Scholar
• Gramantieri L, Ferracin M, Fornari F, Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007;67:6092-9
   PubMed Web of Science ®Google Scholar
• Shimizu S, Takehara T, Hikita H, The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol 2010;52:698-704
   PubMed Web of Science ®Google Scholar
• Hoshida Y, Toffanin S, Lachenmayer A, Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 2010;30:35-51
   PubMed Web of Science ®Google Scholar
• Liu WH, Yeh SH, Lu CC, MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells. Gastroenterology 2009;136:683-93
   PubMed Web of Science ®Google Scholar
• Ji J, Zhao L, Budhu A, Let-7g targets collagen type I alpha2 and inhibits cell migration in hepatocellular carcinoma. J Hepatol 2010;52:690-7
   PubMed Web of Science ®Google Scholar
• Lieberman D. Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 2010;138:2115-26
   PubMed Web of Science ®Google Scholar
• Agostini M, Pucciarelli S, Calore F, miRNAs in colon and rectal cancer: a consensus for their true clinical value. Clin Chim Acta 2010;411:1181-6
   PubMed Web of Science ®Google Scholar
• Michael MZ, O' Connor SM, van Holst Pellekaan NG, Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003;1:882-91
   PubMed Web of Science ®Google Scholar
• Bandres E, Cubedo E, Agirre X, Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 2006;5:29
   PubMed Web of Science ®Google Scholar
• Rossi S, Kopetz S, Davuluri R, MicroRNAs, ultraconserved genes and colorectal cancers. Int J Biochem Cell Biol 2009: published online 2 Jun 2009, doi: 10.1016/j.biocel.2009.05.018
   Google Scholar
• Akao Y, Nakagawa Y, Naoe T. let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 2006;29:903-6
   PubMed Web of Science ®Google Scholar
• Svoboda M, Izakovicova Holla L, Sefr R, Micro- RNAs miR125b and miR137 are frequently upregulated in response to capecitabine chemoradiotherapy of rectal cancer. Int J Oncol 2008;33:541-7
   PubMed Web of Science ®Google Scholar
• Yantiss RK, Goodarzi M, Zhou XK, Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009;33:572-82
   PubMed Web of Science ®Google Scholar
• Chang KH, Mestdagh P, Vandesompele J, MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer 2010;10:173
   PubMed Web of Science ®Google Scholar
• Allgayer H. Pdcd4, a colon cancer prognostic that is regulated by a microRNA. Crit Rev Oncol Hematol 2010;73:185-91
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Wang Z, Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J Gastrointest Surg 2010;14:1170-9
   PubMed Web of Science ®Google Scholar
• Akao Y, Nakagawa Y, Hirata I, Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther 2010;17:398-408
   PubMed Web of Science ®Google Scholar
• Slaby O, Svoboda M, Fabian P, Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007;72:397-402
   PubMed Web of Science ®Google Scholar
• Selcuklu SD, Donoghue MT, Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem Soc Trans 2009;37:918-25
   PubMed Web of Science ®Google Scholar
• Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009;13:39-53
   PubMed Web of Science ®Google Scholar
• Wang V, Wu W. MicroRNA-based therapeutics for cancer. BioDrugs 2009;23(1):15-23
   PubMed Web of Science ®Google Scholar
• Hong L, Fan D. Cancer mucosa antigens: novel immunotherapeutic targets. Expert Opin Ther Targets 2008;12:749-56
   PubMed Web of Science ®Google Scholar
• Scaglione BJ, Salerno E, Balan M, Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Br J Haematol 2007;139:645-57
   PubMed Web of Science ®Google Scholar
• Schroeder A, Levins CG, Cortez C, J Intern Med 2010;267:9-21
   Google Scholar
• Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends Pharmacol Sci 2009;30:341-5
   PubMed Web of Science ®Google Scholar
• Girard M, Jacquemin E, Munnich A, miR-122, a paradigm for the role of microRNAs in the liver. J Hepatol 2008;48:648-56
   PubMed Web of Science ®Google Scholar
• Garzon R, Calin GA, Croce CM. MicroRNAs in cancer. Annu Rev Med 2009;60:167-79
   PubMed Web of Science ®Google Scholar
• van Mil A, Doevendans PA, Sluijter JP. The potential of modulating small RNA activity in vivo. Mini Rev Med Chem 2009;9:235-48
   PubMed Web of Science ®Google Scholar
• Fei J, Lan F, Guo M, Inhibitory effects of anti-miRNA oligonucleotides (AMOs) on A549 cell growth. J Drug Target 2008;16(9):688-93
   PubMed Web of Science ®Google Scholar
• Jankovic R, Radulovic S, Brankovic-Magic M. siRNA and miRNA for the treatment of cancer. J BUON 2009;14:43-9
   Google Scholar
• JSeto AG. The road toward microRNA therapeutics. Int J Biochem Cell Biol 2010: published online 19 May 2010, doi: 10.1016/j.biocel.2010.03.003
   Google Scholar